TX-33 is investigational and has not been approved by the FDA or any regulatory body for orthopedic use. Learn how TX-33 is designed to work. Videos, podcasts, and press coverage open on third-party sites.

I'm Back!^™

Have a comeback story?

Every story on this page started with an injury and ended with two words. We'd like to hear yours.

Share your story

What we're thinking about, and what others are saying.

Latest from Temple OrthoBio

Injuries have decimated Spurs: What is the real cost of relegation?

"You practice all your life, and in one second, you cannot do it anymore. It is scary."

Liam Millar: What a way to say I'm Back!™

The Next Big Sports Investment Isn’t a Team, It’s Sports Medicine

Riley J. Williams III, MD: Physician Video

The Billion Dollars Opportunity in Sports: It isn't what you think

The Business of Athlete Recovery from Elite to Everyday

Women's sports injuries: What to know for all ages and skill levels

The Body as the Balance Sheet

Missing Marquee Matchups: What Happens When the Top 50 in Tennis Break Down?

Private Equity, Venture & Sports: The Core Paradox

"Without Us, There Wouldn't Be a Tournament"

Lost My Identity After My Sports Injury

Four Female Athletes Who Defied Career-Threatening Injuries

In Search of the Holy Grail, Part II

In Search of the Holy Grail, Part I

The Scar Tissue Came Back, and How TX-33 Could Stop It

Sports Medicine for Every Athlete: "I'm Back!™" After Injury, This Is Everything

Temple OrthoBio launch announcement

Temple OrthoBiologics launches with proprietary compound to reduce the formation of fibrosis

Temple Therapeutics spins off orthobiologics company

Dr. Riley J. Williams III named FIFA 2026 Venue Medical Officer

Have a comeback story?

Liam Millar: What a way to say I'm Back!^™

Sports Medicine for Every Athlete: "I'm Back!^™" After Injury, This Is Everything